Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Blood Neoplasia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950328025000640 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839607585679867904 |
|---|---|
| author | Suravi Raychaudhuri Megan Othus Mary-Elizabeth M. Percival Guillermo Garcia-Manero Frederick R. Appelbaum Harry P. Erba Jacob S. Appelbaum |
| author_facet | Suravi Raychaudhuri Megan Othus Mary-Elizabeth M. Percival Guillermo Garcia-Manero Frederick R. Appelbaum Harry P. Erba Jacob S. Appelbaum |
| author_sort | Suravi Raychaudhuri |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d9ceea2d5ab64ef19b25a7df7ee4df0e |
| institution | Matheson Library |
| issn | 2950-3280 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Blood Neoplasia |
| spelling | doaj-art-d9ceea2d5ab64ef19b25a7df7ee4df0e2025-08-01T04:45:34ZengElsevierBlood Neoplasia2950-32802025-08-0123100129Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapySuravi Raychaudhuri0Megan Othus1Mary-Elizabeth M. Percival2Guillermo Garcia-Manero3Frederick R. Appelbaum4Harry P. Erba5Jacob S. Appelbaum6Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WAClinical Research Division, Fred Hutch Cancer Center, Seattle, WADivision of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WADepartment of Leukemia, MD Anderson Cancer Center, Houston, TXDivision of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WADivision of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NCDivision of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA; Correspondence: Jacob S. Appelbaum, Fred Hutch Cancer Center, 825 Eastlake Ave E, MS LG-700, Seattle, WA 98109;http://www.sciencedirect.com/science/article/pii/S2950328025000640 |
| spellingShingle | Suravi Raychaudhuri Megan Othus Mary-Elizabeth M. Percival Guillermo Garcia-Manero Frederick R. Appelbaum Harry P. Erba Jacob S. Appelbaum Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy Blood Neoplasia |
| title | Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy |
| title_full | Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy |
| title_fullStr | Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy |
| title_full_unstemmed | Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy |
| title_short | Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy |
| title_sort | treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive chemotherapy |
| url | http://www.sciencedirect.com/science/article/pii/S2950328025000640 |
| work_keys_str_mv | AT suraviraychaudhuri treatmentdiscontinuationduetotoxicityforpatientswithacutemyeloidleukemiareceivingintensivechemotherapy AT meganothus treatmentdiscontinuationduetotoxicityforpatientswithacutemyeloidleukemiareceivingintensivechemotherapy AT maryelizabethmpercival treatmentdiscontinuationduetotoxicityforpatientswithacutemyeloidleukemiareceivingintensivechemotherapy AT guillermogarciamanero treatmentdiscontinuationduetotoxicityforpatientswithacutemyeloidleukemiareceivingintensivechemotherapy AT frederickrappelbaum treatmentdiscontinuationduetotoxicityforpatientswithacutemyeloidleukemiareceivingintensivechemotherapy AT harryperba treatmentdiscontinuationduetotoxicityforpatientswithacutemyeloidleukemiareceivingintensivechemotherapy AT jacobsappelbaum treatmentdiscontinuationduetotoxicityforpatientswithacutemyeloidleukemiareceivingintensivechemotherapy |